<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/data-integrity-not-scale-is-indias-real-competitive-advantage-chakravarthi-avps-on-indias-pharma-leadership-at-gpacts-2026</loc>
    <lastmod>2026-09-05T10:45:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T00:00:00+05:30</news:publication_date>
      <news:title>Data Integrity, Not Scale, Is India's Real Competitive Advantage - Chakravarthi AVPS on India's Pharma Leadership at GPACTS 2026</news:title>
      <news:keywords>GPACTS 2026, Chakravarthi AVPS, data integrity, pharma IT, ALCOA+, FDA compliance, AI in pharma manufacturing, serialization, Pharma Now, YellowHive Events &amp; Media</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/chakravarthi_avps_keynote_press_release20260905101217.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-emergency-compounding-guidance-neonatal-parenteral-nutrition-outsourcing-facility-shutdown</loc>
    <lastmod>2026-09-05T10:52:36+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T00:00:00+05:30</news:publication_date>
      <news:title>FDA Issues Emergency Guidance After Neonatal PN Supply Shutdowns</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/06a87ebb-1d48-4c86-a0ce-f08d2912c893.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/novartis-pelacarsen-fails-phase-iii-lpa-horizon-cardiovascular-outcomes-trial</loc>
    <lastmod>2026-09-05T10:51:22+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T00:00:00+05:30</news:publication_date>
      <news:title>Novartis Pelacarsen Fails Phase III Lp(a) Trial</news:title>
      <news:keywords>Novartis</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/93b0f050-ef26-4670-982b-c0a504ac6908.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-camizestrant-esr1-mutation-breast-cancer</loc>
    <lastmod>2026-09-05T10:51:25+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T00:00:00+05:30</news:publication_date>
      <news:title>AstraZeneca Wins FDA Approval for Camizestrant in Breast Cancer</news:title>
      <news:keywords>AstraZeneca</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/49f8c10e-4f5e-439f-935c-5f5da57cc2c8.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-camizestrant-cdk46-esr1-mutated-breast-cancer</loc>
    <lastmod>2026-09-05T22:13:41+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T00:00:00+05:30</news:publication_date>
      <news:title>AstraZeneca Wins FDA Accelerated Nod for Camizestrant</news:title>
      <news:keywords>AstraZeneca</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/31144cca-289b-46a7-8933-6a84dacc2dac/1a114dc3-5557-4370-8d16-882fb7e68315.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-flags-zubb-dietary-supplement-hidden-sildenafil-weight-loss</loc>
    <lastmod>2026-09-05T10:50:00+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-05T00:00:00+05:30</news:publication_date>
      <news:title>FDA Flags ZUBB Supplement for Hidden Sildenafil</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/98af20de-8ff4-46c1-980d-23944177d232/cf9eb7bb-35d1-4a26-aed2-bd9cbd255283.png</image:loc>
    </image:image>
  </url>
</urlset>